| ABC | ATP-binding cassette |
| ApoE | apolipoprotein E |
| AUC | area under the curve |
| BBB | blood–brain barrier |
| BCRP | breast cancer resistance protein |
| CBD | cannabidiol |
| CED | convection-enhanced delivery |
| CMC | chemistry, manufacturing, and controls |
| CMT | carrier-mediated transport |
| CNS | central nervous system |
| CPP | cell-penetrating peptide |
| CQA | critical quality attribute |
| CSF | cerebrospinal fluid |
| CYP | cytochrome P450 |
| EVS | extracellular vesicles |
| fu,brain | fraction of unbound drug in brain tissue |
| fu,p | unbound plasma fractions |
| FUS | focused ultrasound |
| GDNF | glial-derived neurotrophic factor |
| GLUT1 | glucose transporter 1 |
| GMP | good manufacturing practice |
| IPSC | induced pluripotent stem cell |
| IR | insulin receptor |
| ISF | interstitial fluid |
| Km | Michaelis constant |
| Kd | dissociation constant |
| Kp,brain | brain-to-plasma partition coefficient |
| Kp,uu | unbound tissue-to-unbound plasma partition coefficient |
| Kp,uu,brain | unbound brain-to-unbound plasma partition coefficient |
| KYNA | kynurenic acid |
| LAT1 | large neutral amino acid transporter 1 |
| LD | linear dichroism |
| LDL | low-density lipoprotein |
| LDLR | low-density lipoprotein receptor |
| LOGD | distribution coefficient |
| LRP1 | low-density lipoprotein receptor-related protein 1 |
| MCT1 | monocarboxylate transporter 1 |
| MCTS | monocarboxylate transporters |
| MRI | magnetic resonance imaging |
| MRPS | multidrug resistance-associated proteins |
| NHP | non-human primate |
| NLCS | nanostructured lipid carriers |
| NMDA | N-methyl-D-aspartate |
| NPS | nanoparticles |
| NR | not reported |
| NVU | neurovascular unit |
| P-gp | P-glycoprotein |
| PAMAM | poly(amidoamine) |
| PAT | process analytical technology |
| PBPK | physiologically based pharmacokinetic |
| PCD | passive cavitation detection |
| PD | pharmacodynamics |
| PDEVS | plant-derived extracellular vesicles |
| PDI | polydispersity index |
| PEG | polyethylene glycol |
| PET | positron emission tomography |
| PK | pharmacokinetics |
| pKa | acid dissociation constant |
| PKPD | pharmacokinetic–pharmacodynamic |
| PLGA | poly(lactic-co-glycolic acid) |
| QbD | quality by design |
| QTPP | quality target product profile |
| RMT | receptor-mediated transcytosis |
| RVG | rabies virus glycoprotein |
| SIRNA | small interfering RNA |
| SLCS | solute carrier transporters |
| SLNS | solid lipid nanoparticles |
| SULT | sulfotransferases |
| TAT | trans-activator of transcription |
| TEER | transendothelial electrical resistance |
| TF | transferrin |
| TFR | transferrin receptor |
| THC | Δ9-tetrahydrocannabinol |
| UGT | UDP-glucuronosyltransferases |
| VEGF | vascular endothelial growth factor |
| VMAX | maximum transport rate |